Safety study of 38 503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital setting

Medicin og biovidenskab

• Ranibizumab 100%
• Intravitreal Injections 88%
• Nurses 54%
• Physicians 47%
• Eye 46%
• Safety 43%
• Endophthalmitis 30%
• Injections 19%
• Retinal Detachment 18%
• Ophthalmology 17%
• Operating Rooms 17%
• Cataract 15%
• Needles 14%
• Anterior Uveitis 11%
• Retinal Diseases 10%
• Retinal Pigments 10%
• Denmark 8%
• Tears 8%
• Drug-Related Side Effects and Adverse Reactions 7%
• Surgeons 5%
• Anti-Bacterial Agents 5%
• Health Care Outcome Assessment 5%
• Hemorrhage 5%
• Confidence Intervals 4%
• Therapeutics 4%